Related Experiment Video
Updated: Jun 12, 2026

09:19
NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
Published on: June 4, 2021
3.7K
Comprehensive and High-Throughput Exploration of Chemical Space Using Broadband 19 F NMR-Based Screening
Andreas Lingel1,2, Anna Vulpetti2, Tony Reinsperger3
1Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, CA, 94608, USA.
Angewandte Chemie (International Ed. in English)
|May 5, 2020
Summary
Fragment-based lead discovery utilizes fluorine-detected NMR for efficient target ligand identification. A new NMR method and fragment library enable rapid screening of thousands of compounds, accelerating drug discovery.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Structural Biology
Background:
- Fragment-based lead discovery is crucial for identifying ligands for disease targets.
- Fluorine-detected NMR (19F NMR) is a sensitive and robust screening technique.
- Efficient chemical space exploration requires optimized fragment libraries and NMR methods.
Purpose of the Study:
- To develop a comprehensive method for assembling a high-quality fragment library.
- To screen for target-specific binders using an optimized NMR approach.
- To enable fast ligandability assessment of new targets.
Main Methods:
- Assembly of a diverse library of nearly 4000 fragments.
- Development of a novel broadband relaxation-edited 19F NMR experiment.
- Optimization of sample composition for maximal compound throughput and minimal measurement time.
Main Results:
- Successful creation of a high-quality, diverse fragment library.
- Screening of the library for target-specific binders within days.
- Demonstration of the NMR experiment's ability to cover the full chemical shift range of 19F motifs in a single measurement.
Conclusions:
- The developed method enables efficient fragment library assembly and screening.
- The novel NMR experiment facilitates rapid identification of diverse binders.
- This approach accelerates the assessment of target ligandability in drug discovery.

